Heterozygous deletion of cyclin C gene (CCNC) has been linked to the progression of acute lymphoblastic leukemia [195], osteosarcoma [196], and thyroid [197] cancer, suggesting that cyclin C is a bona fide tumor suppressor. Here, CCNC is linked to cancer.